Covered recipient · General Payments record
ANTHONY A SHYDOHUB
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2023
$2,520.62
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $615.65 | 22 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $380.01 | 10 |
| Teva Pharmaceuticals USA, Inc. | $38.15 | 2 |
| PFIZER INC. | $35.23 | 2 |
| SK Life Science, Inc. | $31.89 | 1 |
| UCB, Inc. | $25.36 | 1 |
| Aprecia Pharmaceuticals, LLC | $23.43 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.87 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.22 | 1 |
| Celgene Corporation | $15.26 | 1 |
| Alnylam Pharmaceuticals Inc. | $13.21 | 1 |
| Lilly USA, LLC | $13.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $9.44 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998996567 | CMS |
| AbbVie Inc. | $122.55 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998996571 | CMS |
| AbbVie Inc. | $20.53 | 02/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998996575 | CMS |
| AbbVie Inc. | $20.43 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998996579 | CMS |
| AbbVie Inc. | $33.48 | 04/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998996583 | CMS |
| AbbVie Inc. | $21.60 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998996587 | CMS |
| AbbVie Inc. | $99.06 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998996591 | CMS |
| AbbVie Inc. | $17.88 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998996595 | CMS |
| AbbVie Inc. | $20.05 | 07/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998996599 | CMS |
| AbbVie Inc. | $14.99 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998996603 | CMS |
| Alexion Pharmaceuticals, Inc. | $22.87 | 07/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016988745 | CMS |
| Alnylam Pharmaceuticals Inc. | $13.21 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006165561 | CMS |
| Aprecia Pharmaceuticals, LLC | $23.43 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052844425 | CMS |
| Celgene Corporation | $15.26 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016174591 | CMS |
| Lilly USA, LLC | $13.02 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031266281 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.22 | 05/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014817401 | CMS |
| PFIZER INC. | $15.38 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050541969 | CMS |
| PFIZER INC. | $19.85 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049410827 | CMS |
| SK Life Science, Inc. | $31.89 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054640729 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.66 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056847985 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.49 | 08/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056848069 | CMS |
| UCB, Inc. | $25.36 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021962291 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.